- Gainers: CounterPath (NASDAQ:CPAH) +32%.
- Genprex (NASDAQ:GNPX) +31%.
- Happiness Biotech (NASDAQ:HAPP) +25%.
- Exterran (NYSE:EXTN) +20%.
- Inovio Pharmaceuticals (NASDAQ:INO) +20%.
- BioXcel Therapeutics (NASDAQ:BTAI) +19%.
- Brainstorm Cell Therapeutics (NASDAQ:BCLI) +19%.
- Redfin (NASDAQ:RDFN) +15%.
- Kelly Services (NASDAQ:KELYA) +14%.
- Alpha Pro Tech (NYSEMKT:APT) +14%.
- Losers: NeuroBo Pharmaceuticals (NASDAQ:NRBO) -28%.
- XBiotech (NASDAQ:XBIT) -23%.
- Marchex (NASDAQ:MCHX) -22%.
- Catalyst Biosciences (NASDAQ:CBIO) -21%.
- SenesTech (NASDAQ:SNES) -18%.
- Gravity (NASDAQ:GRVY) -16%.
- SunPower (NASDAQ:SPWR) -16%.
- AVROBIO (NASDAQ:AVRO) -16%.
- Nu Skin Enterprises (NYSE:NUS) -15%.
- Trio-Tech International (NYSEMKT:TRT) -14%.